ArticleBritish journal of cancer2012

Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours.

G Freyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.